Sign up to save tools and stay up to date with the latest in AI
bg
bg
1

New Teladoc, same acquisition strategy

Feb 06, 2025 - statnews.com
The article discusses recent developments in health technology, focusing on Amazon Pharmacy's RxPass subscription, which reportedly improves medication adherence by offering 60 generic medications for a $5 monthly fee. A study published in JAMA Network Open suggests that RxPass users are more likely to refill prescriptions, indicating better health outcomes. The article also highlights ongoing political challenges in extending health tech-friendly policies, such as the Medicare hospital-at-home program, amid government funding uncertainties.

Additionally, the article covers Teladoc Health's acquisition of Catapult Health for $65 million to expand its chronic disease business, continuing its strategy of growth through acquisitions. It also reports on fundraising activities, including Zest Health's $13 million raise and Lynx's $27 million raise, while noting the shutdown of virtual health clinics Caraway and Miga Health. The article concludes with a brief mention of Benevolent AI's delisting from the Dutch stock exchange and other industry news.

Key takeaways:

  • Amazon's RxPass subscription service is associated with improved medication adherence, as shown by a study published in JAMA Network Open.
  • Hospital at home advocates are pushing for a five-year extension of a Medicare program that allows inpatient care at home, amid uncertain government funding.
  • Teladoc Health plans to acquire Catapult Health for $65 million to expand its chronic disease business, continuing its acquisition strategy.
  • Several health tech companies, including Zest Health and Axena Health, have raised funds, while others like Caraway and Miga Health have shut down.
View Full Article

Comments (0)

Be the first to comment!